{"entity":{"type":"insider","cik":"0001724097","url":"/insider/0001724097","json_url":"/insider/0001724097.json","name":"ABERNETHY MATT","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":34,"n_filings":24,"first":"2018-12-06","last":"2025-02-14","span_basis":"filed_date"},"name_variants":[{"name":"ABERNETHY MATT","source":"filing","n_filings":24,"first_seen":"2018-12-06","last_seen":"2025-02-14"}],"transactions":[{"id":4904425,"accession":"0000914475-25-000055","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000914475-25-000055","line_url":"/filing/0000914475-25-000055","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001724097","owner_name":"ABERNETHY MATT","owner_display_name":"ABERNETHY MATT","owner_url":"/insider/0001724097","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2558.0,"shares_display":"2,558","price_per_share":116.85817638780297,"price_display":"116.86","price_state":"stated","total_value":298923.2152,"total_display":"298,923.22","total_whole":"298,923","shares_owned_after":34775.0,"shares_owned_after_display":"34,775","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-13","filed_date":"2025-02-14","scope":"insider","n_lines":2},{"id":4789116,"accession":"0000914475-25-000046","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000914475-25-000046","line_url":"/filing/0000914475-25-000046#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001724097","owner_name":"ABERNETHY MATT","owner_display_name":"ABERNETHY MATT","owner_url":"/insider/0001724097","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":980.0,"shares_display":"980","price_per_share":118.274,"price_display":"118.27","price_state":"stated","total_value":115908.52,"total_display":"115,908.52","total_whole":"115,909","shares_owned_after":33561.0,"shares_owned_after_display":"33,561","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-10","filed_date":"2025-02-12","scope":"insider"},{"id":4058468,"accession":"0000914475-25-000020","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000914475-25-000020","line_url":"/filing/0000914475-25-000020#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001724097","owner_name":"ABERNETHY MATT","owner_display_name":"ABERNETHY MATT","owner_url":"/insider/0001724097","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1283.0,"shares_display":"1,283","price_per_share":152.8728,"price_display":"152.87","price_state":"stated","total_value":196135.8024,"total_display":"196,135.80","total_whole":"196,136","shares_owned_after":32681.0,"shares_owned_after_display":"32,681","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-31","filed_date":"2025-02-04","scope":"insider"},{"id":2885006,"accession":"0000914475-24-000193","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000914475-24-000193","line_url":"/filing/0000914475-24-000193#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001724097","owner_name":"ABERNETHY MATT","owner_display_name":"ABERNETHY MATT","owner_url":"/insider/0001724097","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14100.0,"shares_display":"14,100","price_per_share":150.3792,"price_display":"150.38","price_state":"stated","total_value":2120346.72,"total_display":"2,120,346.72","total_whole":"2,120,347","shares_owned_after":31528.0,"shares_owned_after_display":"31,528","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-13","filed_date":"2024-08-15","scope":"insider"},{"id":3200082,"accession":"0000914475-24-000170","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000914475-24-000170","line_url":"/filing/0000914475-24-000170#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001724097","owner_name":"ABERNETHY MATT","owner_display_name":"ABERNETHY MATT","owner_url":"/insider/0001724097","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":150.0411,"price_display":"150.04","price_state":"stated","total_value":135036.99,"total_display":"135,036.99","total_whole":"135,037","shares_owned_after":31528.0,"shares_owned_after_display":"31,528","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-16","filed_date":"2024-07-18","scope":"insider"},{"id":2107038,"accession":"0000914475-24-000121","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000914475-24-000121","line_url":"/filing/0000914475-24-000121#line-4","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001724097","owner_name":"ABERNETHY MATT","owner_display_name":"ABERNETHY MATT","owner_url":"/insider/0001724097","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":140.2406,"price_display":"140.24","price_state":"stated","total_value":2103609.0,"total_display":"2,103,609.00","total_whole":"2,103,609","shares_owned_after":31528.0,"shares_owned_after_display":"31,528","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-15","filed_date":"2024-05-16","scope":"insider"},{"id":2107033,"accession":"0000914475-24-000121","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000914475-24-000121","line_url":"/filing/0000914475-24-000121#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001724097","owner_name":"ABERNETHY MATT","owner_display_name":"ABERNETHY MATT","owner_url":"/insider/0001724097","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":135.6551,"price_display":"135.66","price_state":"stated","total_value":2034826.5,"total_display":"2,034,826.50","total_whole":"2,034,827","shares_owned_after":31528.0,"shares_owned_after_display":"31,528","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-14","filed_date":"2024-05-16","scope":"insider"},{"id":2976180,"accession":"0000914475-24-000067","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914475-24-000067","line_url":"/filing/0000914475-24-000067#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001724097","owner_name":"ABERNETHY MATT","owner_display_name":"ABERNETHY MATT","owner_url":"/insider/0001724097","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1352.0,"shares_display":"1,352","price_per_share":132.8488,"price_display":"132.85","price_state":"stated","total_value":179611.5776,"total_display":"179,611.58","total_whole":"179,612","shares_owned_after":31528.0,"shares_owned_after_display":"31,528","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-13","filed_date":"2024-02-15","scope":"insider"},{"id":2138815,"accession":"0000914475-24-000043","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000914475-24-000043","line_url":"/filing/0000914475-24-000043#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001724097","owner_name":"ABERNETHY MATT","owner_display_name":"ABERNETHY MATT","owner_url":"/insider/0001724097","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":980.0,"shares_display":"980","price_per_share":134.2135,"price_display":"134.21","price_state":"stated","total_value":131529.23,"total_display":"131,529.23","total_whole":"131,529","shares_owned_after":30314.0,"shares_owned_after_display":"30,314","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-08","filed_date":"2024-02-08","scope":"insider"},{"id":2138811,"accession":"0000914475-24-000043","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914475-24-000043","line_url":"/filing/0000914475-24-000043#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001724097","owner_name":"ABERNETHY MATT","owner_display_name":"ABERNETHY MATT","owner_url":"/insider/0001724097","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1280.0,"shares_display":"1,280","price_per_share":142.1878,"price_display":"142.19","price_state":"stated","total_value":182000.384,"total_display":"182,000.38","total_whole":"182,000","shares_owned_after":29434.0,"shares_owned_after_display":"29,434","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-06","filed_date":"2024-02-08","scope":"insider"},{"id":2817214,"accession":"0000914475-24-000022","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914475-24-000022","line_url":"/filing/0000914475-24-000022#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001724097","owner_name":"ABERNETHY MATT","owner_display_name":"ABERNETHY MATT","owner_url":"/insider/0001724097","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1283.0,"shares_display":"1,283","price_per_share":140.7161,"price_display":"140.72","price_state":"stated","total_value":180538.7563,"total_display":"180,538.76","total_whole":"180,539","shares_owned_after":28284.0,"shares_owned_after_display":"28,284","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-31","filed_date":"2024-02-02","scope":"insider"},{"id":8704235,"accession":"0001209191-23-047127","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-047127","line_url":"/filing/0001209191-23-047127#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001724097","owner_name":"ABERNETHY MATT","owner_display_name":"ABERNETHY MATT","owner_url":"/insider/0001724097","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2132.0,"shares_display":"2,132","price_per_share":107.3914,"price_display":"107.39","price_state":"stated","total_value":228958.4648,"total_display":"228,958.46","total_whole":"228,958","shares_owned_after":27131.0,"shares_owned_after_display":"27,131","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-21","filed_date":"2023-08-23","scope":"insider"},{"id":8677639,"accession":"0001209191-23-007905","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-23-007905","line_url":"/filing/0001209191-23-007905#line-5","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001724097","owner_name":"ABERNETHY MATT","owner_display_name":"ABERNETHY MATT","owner_url":"/insider/0001724097","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":980.0,"shares_display":"980","price_per_share":104.1939,"price_display":"104.19","price_state":"stated","total_value":102110.022,"total_display":"102,110.02","total_whole":"102,110","shares_owned_after":25213.0,"shares_owned_after_display":"25,213","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-08","filed_date":"2023-02-08","scope":"insider"},{"id":8677636,"accession":"0001209191-23-007905","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-007905","line_url":"/filing/0001209191-23-007905","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001724097","owner_name":"ABERNETHY MATT","owner_display_name":"ABERNETHY MATT","owner_url":"/insider/0001724097","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26328.0,"shares_display":"26,328","price_per_share":102.40453469690064,"price_display":"102.40","price_state":"stated","total_value":2696106.5895,"total_display":"2,696,106.59","total_whole":"2,696,107","shares_owned_after":35824.0,"shares_owned_after_display":"35,824","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-07","filed_date":"2023-02-08","scope":"insider","n_lines":3},{"id":8677630,"accession":"0001209191-23-007905","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-007905","line_url":"/filing/0001209191-23-007905#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001724097","owner_name":"ABERNETHY MATT","owner_display_name":"ABERNETHY MATT","owner_url":"/insider/0001724097","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1280.0,"shares_display":"1,280","price_per_share":105.6667,"price_display":"105.67","price_state":"stated","total_value":135253.376,"total_display":"135,253.38","total_whole":"135,253","shares_owned_after":22507.0,"shares_owned_after_display":"22,507","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-06","filed_date":"2023-02-08","scope":"insider"},{"id":8701257,"accession":"0001209191-23-006256","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-006256","line_url":"/filing/0001209191-23-006256#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001724097","owner_name":"ABERNETHY MATT","owner_display_name":"ABERNETHY MATT","owner_url":"/insider/0001724097","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1283.0,"shares_display":"1,283","price_per_share":109.9827,"price_display":"109.98","price_state":"stated","total_value":141107.8041,"total_display":"141,107.80","total_whole":"141,108","shares_owned_after":21357.0,"shares_owned_after_display":"21,357","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-31","filed_date":"2023-02-02","scope":"insider"},{"id":6294761,"accession":"0001209191-22-008203","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-008203","line_url":"/filing/0001209191-22-008203#line-3","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001724097","owner_name":"ABERNETHY MATT","owner_display_name":"ABERNETHY MATT","owner_url":"/insider/0001724097","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":980.0,"shares_display":"980","price_per_share":79.6506,"price_display":"79.65","price_state":"stated","total_value":78057.588,"total_display":"78,057.59","total_whole":"78,058","shares_owned_after":20204.0,"shares_owned_after_display":"20,204","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-08","filed_date":"2022-02-09","scope":"insider"},{"id":6294758,"accession":"0001209191-22-008203","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-008203","line_url":"/filing/0001209191-22-008203","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001724097","owner_name":"ABERNETHY MATT","owner_display_name":"ABERNETHY MATT","owner_url":"/insider/0001724097","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3310.0,"shares_display":"3,310","price_per_share":80.79402296072507,"price_display":"80.79","price_state":"stated","total_value":267428.216,"total_display":"267,428.22","total_whole":"267,428","shares_owned_after":18175.0,"shares_owned_after_display":"18,175","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-07","filed_date":"2022-02-09","scope":"insider","n_lines":2},{"id":4344702,"accession":"0001209191-21-067870","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-067870","line_url":"/filing/0001209191-21-067870#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001724097","owner_name":"ABERNETHY MATT","owner_display_name":"ABERNETHY MATT","owner_url":"/insider/0001724097","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1645.0,"shares_display":"1,645","price_per_share":82.5851,"price_display":"82.59","price_state":"stated","total_value":135852.4895,"total_display":"135,852.49","total_whole":"135,852","shares_owned_after":16349.0,"shares_owned_after_display":"16,349","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-01","filed_date":"2021-12-03","scope":"insider"},{"id":5035440,"accession":"0001209191-21-009132","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-009132","line_url":"/filing/0001209191-21-009132","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001724097","owner_name":"ABERNETHY MATT","owner_display_name":"ABERNETHY MATT","owner_url":"/insider/0001724097","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2910.0,"shares_display":"2,910","price_per_share":116.81838934707903,"price_display":"116.82","price_state":"stated","total_value":339941.513,"total_display":"339,941.51","total_whole":"339,942","shares_owned_after":14869.0,"shares_owned_after_display":"14,869","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-08","filed_date":"2021-02-09","scope":"insider","n_lines":2},{"id":3173886,"accession":"0001209191-20-061146","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-061146","line_url":"/filing/0001209191-20-061146#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001724097","owner_name":"ABERNETHY MATT","owner_display_name":"ABERNETHY MATT","owner_url":"/insider/0001724097","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1645.0,"shares_display":"1,645","price_per_share":94.6632,"price_display":"94.66","price_state":"stated","total_value":155720.964,"total_display":"155,720.96","total_whole":"155,721","shares_owned_after":11494.0,"shares_owned_after_display":"11,494","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-01","filed_date":"2020-12-02","scope":"insider"},{"id":2913256,"accession":"0001209191-20-058532","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-058532","line_url":"/filing/0001209191-20-058532#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001724097","owner_name":"ABERNETHY MATT","owner_display_name":"ABERNETHY MATT","owner_url":"/insider/0001724097","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2257.0,"shares_display":"2,257","price_per_share":90.7444,"price_display":"90.74","price_state":"stated","total_value":204810.1108,"total_display":"204,810.11","total_whole":"204,810","shares_owned_after":10014.0,"shares_owned_after_display":"10,014","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-12","filed_date":"2020-11-16","scope":"insider"},{"id":2471709,"accession":"0001209191-20-045716","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-045716","line_url":"/filing/0001209191-20-045716#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001724097","owner_name":"ABERNETHY MATT","owner_display_name":"ABERNETHY MATT","owner_url":"/insider/0001724097","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2257.0,"shares_display":"2,257","price_per_share":118.8994,"price_display":"118.90","price_state":"stated","total_value":268355.9458,"total_display":"268,355.95","total_whole":"268,356","shares_owned_after":7983.0,"shares_owned_after_display":"7,983","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-05","filed_date":"2020-08-07","scope":"insider"},{"id":2543751,"accession":"0001209191-20-028394","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-028394","line_url":"/filing/0001209191-20-028394#line-2","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001724097","owner_name":"ABERNETHY MATT","owner_display_name":"ABERNETHY MATT","owner_url":"/insider/0001724097","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":110.2089,"price_display":"110.21","price_state":"stated","total_value":1653133.5,"total_display":"1,653,133.50","total_whole":"1,653,134","shares_owned_after":5953.0,"shares_owned_after_display":"5,953","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-07","filed_date":"2020-05-11","scope":"insider"},{"id":2831585,"accession":"0001209191-20-026302","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-026302","line_url":"/filing/0001209191-20-026302#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001724097","owner_name":"ABERNETHY MATT","owner_display_name":"ABERNETHY MATT","owner_url":"/insider/0001724097","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1741.0,"shares_display":"1,741","price_per_share":102.49,"price_display":"102.49","price_state":"stated","total_value":178435.09,"total_display":"178,435.09","total_whole":"178,435","shares_owned_after":5953.0,"shares_owned_after_display":"5,953","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-28","filed_date":"2020-04-30","scope":"insider"},{"id":3166046,"accession":"0001209191-20-026062","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-026062","line_url":"/filing/0001209191-20-026062#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001724097","owner_name":"ABERNETHY MATT","owner_display_name":"ABERNETHY MATT","owner_url":"/insider/0001724097","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1934.0,"shares_display":"1,934","price_per_share":99.5175,"price_display":"99.52","price_state":"stated","total_value":192466.845,"total_display":"192,466.84","total_whole":"192,467","shares_owned_after":7694.0,"shares_owned_after_display":"7,694","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-24","filed_date":"2020-04-28","scope":"insider"},{"id":3310013,"accession":"0001209191-20-008478","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-008478","line_url":"/filing/0001209191-20-008478#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001724097","owner_name":"ABERNETHY MATT","owner_display_name":"ABERNETHY MATT","owner_url":"/insider/0001724097","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2030.0,"shares_display":"2,030","price_per_share":103.353,"price_display":"103.35","price_state":"stated","total_value":209806.59,"total_display":"209,806.59","total_whole":"209,807","shares_owned_after":5701.0,"shares_owned_after_display":"5,701","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-07","filed_date":"2020-02-11","scope":"insider"},{"id":8103325,"accession":"0001209191-19-059146","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-059146","line_url":"/filing/0001209191-19-059146#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001724097","owner_name":"ABERNETHY MATT","owner_display_name":"ABERNETHY MATT","owner_url":"/insider/0001724097","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1645.0,"shares_display":"1,645","price_per_share":116.3285,"price_display":"116.33","price_state":"stated","total_value":191360.3825,"total_display":"191,360.38","total_whole":"191,360","shares_owned_after":3876.0,"shares_owned_after_display":"3,876","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-02","filed_date":"2019-12-04","scope":"insider"},{"id":6143164,"accession":"0001209191-18-061372","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-061372","line_url":"/filing/0001209191-18-061372#line-1","is_derivative":false,"issuer_cik":"0000914475","issuer_name":"NEUROCRINE BIOSCIENCES INC","issuer_ticker":"NBIX","issuer_name_source":null,"issuer_url":"/issuer/0000914475","owner_cik":"0001724097","owner_name":"ABERNETHY MATT","owner_display_name":"ABERNETHY MATT","owner_url":"/insider/0001724097","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1178.0,"shares_display":"1,178","price_per_share":89.9997,"price_display":"90.00","price_state":"stated","total_value":106019.6466,"total_display":"106,019.65","total_whole":"106,020","shares_owned_after":1947.0,"shares_owned_after_display":"1,947","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-03","filed_date":"2018-12-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":34,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":34,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":34},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000914475","name":"NEUROCRINE BIOSCIENCES INC","url":"/issuer/0000914475","role":"Officer (Chief Financial Officer)","n_filings":24,"first_seen":"2018-12-06","last_seen":"2025-02-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001724097","retrieved_at":"2026-08-25T01:19:20+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}